Ashley York, NP
Adult Health · Hoover, ALNPI 1750797197
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,023 of the $10,953 with a category attached, or 64.1%. Astellas Pharma US Inc accounts for 73.3% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $5,153 and has fallen 67.1% since, to $1,695 in 2025. Among adult health clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $79.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$8K
- Grifols USA, LLC$353
- Amgen$348
- Regeneron Healthcare Solutions, Inc.$316
- AstraZeneca$303
- Harmony Biosciences LLC$213
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$7,02364%
- Travel & lodging$8728%
- Food & beverage$2,98227%
- Education$771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $8,033 |
| Grifols USA, LLC | 14 | $353 |
| Amgen | 17 | $348 |
| Regeneron Healthcare Solutions, Inc. | 13 | $316 |
| AstraZeneca | 12 | $303 |
| Harmony Biosciences LLC | 6 | $213 |
| Boehringer Ingelheim | 8 | $201 |
| Jazz Pharmaceuticals Inc. | 7 | $184 |
| Mallinckrodt Hospital Products Inc. | 8 | $169 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Johnson & Johnson | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $73 |
| Sanofi | 2 | $60 |
| Mylan Specialty L.p. | 3 | $53 |
| Baxter Healthcare | 2 | $48 |
| Resmed Corp | 3 | $46 |
| GSK | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Pfizer | 2 | $33 |
| Viatris Specialty LLC | 1 | $23 |
| Merck | 1 | $22 |
| United Therapeutics Corporation | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Inogen, Inc. | 2 | $17 |
| Pulmonx Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,953 in reported general payments places this provider in the 95th percentile of 308 adult health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Hoover
- Olivia ViseHoover$15K
- Wendy CantrellMountain Brk$276K
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Lindsay SmithPelham$14K
- Alaina OdomAlabaster$14K
- Holly CluckMontgomery$12K
- James CrumbTrussville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.